Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy

Elevated pretreatment serum interleukin-10 (IL-10) is associated with inferior progression-free survival (PFS) in patients with Hodgkin's disease (HD) treated with ABVD or equivalent regimens. Therefore, we explored the association of serum IL-10 with presenting features and PFS in HD patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia & lymphoma 2004-10, Vol.45 (10), p.2085-2092
Hauptverfasser:	Visco, Carlo, Vassilakopoulos, Theodoros P, Kliche, Kay Oliver, Nadali, Gianpaolo, Viviani, Simonetta, Bonfante, Valeria, Medeiros, L Jeffrey, Notti, P, Rassidakis, George Z, Peethambaram, Prema, Wilder, Richard, Witzig, Thomas, Gianni, Massimo, Bonadonna, Gianni, Pizzolo, Giovanni, Pangalis, Gerassimos A, Cabanillas, Fernando, Sarris, Andreas H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult beta 2-Glycoprotein I Disease-Free Survival Female Follow-Up Studies Glycoproteins - blood Hodgkin Disease - blood Hodgkin Disease - mortality Hodgkin Disease - radiotherapy Hodgkin's disease Human immunodeficiency virus Humans Interleukin-10 Interleukin-10 - blood Male Middle Aged Multivariate Analysis Prognosis Prognostic factors Radiotherapy Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!